从QbD的角度来看,眼科脂质体的设计和开发
Kaustubh Pawar1, Karimunnisa Shaikh1
1Progressive Education Society's Modern College of Pharmacy, Savitribai Phule Pune University, Pune, India.
Current pharmaceutical design
|July 18, 2024
概括
延迟释放脂质体为眼科药物提供了改善的眼部生物可用性,克服了传统眼药的局限性. 这种新型的输送系统增强了角膜接触时间和药物吸收,提高了患者的服药性.
科学领域:
- 制药科学 制药科学
- 药物输送系统 药物输送系统
- 眼科治疗学 眼科治疗学
背景情况:
- 局部眼科溶液由于催和角膜粘附性差等因素而遭受眼部生物利用性差.
- 水友性药物在经角膜吸收方面面临挑战,频繁的剂量减少了患者的服药量.
研究的目的:
- 审查脂质体在眼科药物输送中的好处.
- 讨论以设计质量 (QbD) 为指导的脂质体配方开发.
主要方法:
- 讨论脂质体组成,制备方法和质量属性.
- 关于质量目标产品配置文件 (QTPP),关键质量属性 (CQA),关键材料属性 (CMA) 和关键过程参数 (CPP) 的建议.
主要成果:
- 脂质体通过延迟释放和改善角膜粘附来增强眼部药物递送.
- 脂质体防止角膜前药物清除,延长角膜接触时间,并促进角膜间吸收.
结论:
- 脂质体代表了一种有希望的方法来克服传统眼科解决方案的局限性.
- 本综述为使用QbD原则开发高质量的眼科脂质体提供了一个框架.
相关概念视频
Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...


